help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
 

Advertisement


Advertisement


American 
Pharmacists 
Month

APhA CEO Blog

APhA 
Foundation



2010 International Pharmaceutical Federation PSWC and AAPS Annual 
Meeting

Print this page

APhA pushes medication adherence

Rep. Henry Waxman (D-CA) receives letter, co-signed by APhA, urging the inclusion of medication adherence in health care reform legislation.

APhA was one of the signatories to a July 17 letter urging Rep. Henry Waxman (D-CA), Chairman of the House Energy and Commerce Committee, to include medication adherence initiatives when refining upcoming health reform legislation efforts. Cosigned by a number of stakeholders, the letter linked improved patient health and controlled health care costs with effective prevention and chronic care management. “The health system is spending upwards of $300 billion on unnecessary hospital (re-) admissions, visits to health care practitioners, and costly advanced treatments,” it continued. “Through simple initiatives that promote adherence such as employer- or community- based counseling programs, incentives within the health care system, reminder systems, and broad-based public education, we can potentially save thousands of dollars per patient annually.”    

As Chair of the Energy and Commerce Committee, Waxman heads what many consider to be the key committee in deciding the fate of health care reform in the next few weeks.  Absent the votes he needs to pass a bill out of his committee, House leadership is considering skipping his committee and taking the bill straight to the floor of the House. Waxman isn’t new to the political process.  He has been consistently active in health-related legislation during his 34 years in Congress, sponsoring numerous bills, including: the Ryan White CARE Act, the Nutrition Labeling and Education Act, the Breast and Cervical Cancer Mortality Prevention Act, the Safe Medical Devices Act, the Patent Term Restoration and Drug Competition Act, and the Orphan Drug Act. He has also authored laws to improve the quality of nursing homes and home health services and has helped to set policy for childhood immunization programs, vaccine compensation, tobacco education programs, communicable disease research, community and migrant health centers, maternal and child health care, family planning centers, health maintenance organizations, and drug regulation and reform. 

Related resources on www.pharmacist.com

Beth Farnstrom (bfarnstrom)
Posted July 27 2009, 10:30 am EDT